Market LIVE
Published markets; coverage varies by country
Product profile · United States

VYKAT XR

 ·  Patent Litigation & Settlement History ↓

IngredientDIAZOXIDE CHOLINE
Application typeNDA
Application216665
Product003
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
Strength150MG
Approval date2025-03-26
Marketing statusPrescription
Status event—
ApplicantSOLENO
Product source

Current GenericRadar decision

Year2035
SelectionCANDIDATE
ReviewFINAL
Anchor typeDS_EQUIVALENT_PATENT
Anchor date2035-11-12
Patent anchor2035-11-12
Exclusivity anchor2032-03-26
Protection date2035-11-12
First Final ANDA—
Status event—

ANCHOR_NO_TAIL; US:NDA:216665:003; exact Final ANDA not verified; not proof of generic absence

Patent estate

PatentEffective dateOfficial listingTRUE_DSDS gradeClaim classification / basisPTEPEDFamily
75727892026-12-20DS/DP —NNDP
| B1C03 issued-claim review2026-10-15: DP
———
75727892026-12-20ORANGE_BOOK —NNDP
English description not available.
———
77997772029-03-05DS —NNDP
| B1C03 issued-claim review2026-10-15: DP
———
77997772029-03-05ORANGE_BOOK —NNDP
English description not available.
———
121788232035-11-12U U-4167NNU
| B1C03 issued-claim review2026-10-15: U
———
121788232035-11-12ORANGE_BOOK U-4167NNU
English description not available.
———
123433482035-11-12U U-4211NNU
| B1C03 issued-claim review2026-10-15: U
———
123433482035-11-12ORANGE_BOOK U-4211NNU
English description not available.
———
124198952035-11-12U U-4275NYU
| B1C03 issued-claim review2026-10-15: U
———
124198952035-11-12ORANGE_BOOK U-4275NYU
English description not available.
———
97573842035-11-12U U-4167NNU
| B1C03 issued-claim review2026-10-15: U
———
97573842035-11-12ORANGE_BOOK U-4167NNU
English description not available.
———

Regulatory exclusivity

CodeStart dateEnd dateScopeEntire productAll indicationsFull coverage dateCombinationSource
NP2025-03-262028-03-26English description not available.YY2028-03-26—Source
NP2025-03-262028-03-26English description not available.YY2028-03-26
ODE-532
Full coverage date: 2028-03-26
Source
ODE-5322025-03-262032-03-26English description not available.YY2032-03-26—Source
ODE-5322025-03-262032-03-26English description not available.YY2032-03-26
ODE-532
Full coverage date: 2032-03-26
Source

2026-10-10 · CURRENT_SOURCE_RECORDS_FOUND · Historical coverage: NOT_COMPLETE

Generic approval evidence

Application / productEventFinal dateTentative dateApplicantAuthorized genericExact mappingSource
No generic approval facts are linked to this product.

Market Entry Information

API filings, authorized generics and linked regulatory milestones.

API Master Files & Certifications 0 records

Ingredient-level registrations from linked public manufacturer portfolios. A filing does not establish supply to this finished product. DMFs are not FDA approvals.

APIHolder / manufacturerHolder countryFiling typeNumberStatusFiled dateAvailable for referenceSourceLast verified
No master-file or certification records are linked through public manufacturer portfolios.

Authorized Generics 0 records

Authorized generics are shown separately from independent ANDA approvals.

Application / productApplicantEvent / status First marketed Product mappingSourceLast verified
No authorized-generic records are linked to this product.

Tentative ANDA Approvals 0 records

Tentative approval is not final approval. Historical tentative approvals remain visible after a linked final approval.

Application / productApplicantEvent / status Tentative date Follow-up final approvalProduct mappingSourceLast verified
No tentative-approval records are linked to this product.

Paragraph IV Challenges 0 records

Paragraph IV challenges below are sourced from legal records separately from FDA approvals. An ANDA filing, lawsuit or settlement does not establish final approval or commercial launch.

Application / productApplicantEvent / status Certification event date Product mappingSourceLast verified
No structured Paragraph IV certification events are linked in the available approval evidence.

Final ANDA Approvals 0 records

Approval dates do not establish commercial launch. Product mapping is shown for each linked record.

Application / productApplicantEvent / status Final approval date Product mappingSourceLast verified
No final-approval records are linked to this product.
Decision evidence (9)
TypeDateRoleBasisSource
PATENT2026-12-20HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2029-03-05HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2035-11-12HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2035-11-12HISTORICAL_CONTEXTEnglish description not available.Source
PATENT2035-11-12CANONICAL_ANCHOREnglish description not available.Source
PATENT2035-11-12HISTORICAL_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_EXCLUSIVITY—REGULATORY_SCOPE_CONTEXTEnglish description not available.Source
REGULATORY_STATUS2035-11-12CANONICAL_DECISIONANCHOR_NO_TAIL; US:NDA:216665:003; exact Final ANDA not verified; not proof of generic absenceSource
Independent legal-event information

Litigation & Settlement History

Settlement launch rights generally apply only to the named parties and product scope. These records do not change GenericRadar patent/exclusivity anchors or current decisions.

No litigation or settlement record currently linked to this product.